Gerlie Gieser

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia

Aviva C. Krauss, Xin Gao, Liang Li et al. · Clinical Cancer Research · 2018 · 327 citations · Full text

Medicine, Oncology, Pharmacology +17

Improving Pediatric Dosing Through Pediatric Initiatives: What We Have Learned

William Rodriguez, Arzu Selen, Debbie Avant et al. · PEDIATRICS · 2008 · 160 citations

Pharmacy, Pediatrics, Pharmacology +17

FDA Approval: Alectinib for the Treatment of Metastatic, ALK-Positive Non–Small Cell Lung Cancer Following Crizotinib

Erin Larkins, Gideon M. Blumenthal, Huanyu Chen et al. · Clinical Cancer Research · 2016 · 129 citations

Medicine, Oncology, Pharmacology +13

FDA Workshop on Pharmacodynamic and Pharmacogenomic Biomarkers in Solid Organ Transplantation28 September 2010Silver Spring, MD

Gerlie Gieser, Hiroto Harigaya, Philip M. Colangelo et al. · Clinical Pharmacology & Therapeutics · 2011 · 11 citations

Medicine, Pharmacokinetics, Pharmacology +17